Xenon Pharmaceuticals XENE Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's deferred taxes?
- Xenon Pharmaceuticals (XENE) reported deferred taxes of $447K in Q1 2026.
- How has Xenon Pharmaceuticals's deferred taxes changed year-over-year?
- Xenon Pharmaceuticals's deferred taxes increased by 136.9% year-over-year, from -$1.21M to $447K.
- What is the long-term trend for Xenon Pharmaceuticals's deferred taxes?
- Over 3 years (2021 to 2025), Xenon Pharmaceuticals's deferred taxes has grown at a 280.6% compound annual growth rate (CAGR), from $58K to -$3.2M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.